Selective CDK4/6 Inhibitors in Cancer: Moving Beyond Breast Cancer

Share

Program Content

Activities

  • Downloadable Slideset
    Selective CDK4/6 Inhibitors in Cancer: Moving Beyond Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 14, 2017

    Expires: April 13, 2018

  • Targeting CDK4/6
    Targeting CDK4/6 in Patients With Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • CDK4/6 Inhibitors: Activity and Resistance
    Clinical Development of Selective CDK4/6 Inhibitors: Monotherapy Activity and Mechanisms of Resistance
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • CDK4/6 Inhibitor Combinations
    Combination Approaches and Extending the Use of CDK4/6 Inhibitors Beyond ER-Positive Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

Provided by

ProCE Banner

Supporters

Pfizer, Inc.